fashion -WSS

fashion

author：comprehensive 2025-08-11 07:58:37 - browse：15878

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Methadone treatment changes are coming. Do they go far enough?

leisure time

WSS

Physicians and social media: If you see something, say something?

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

No Labels group has 'steep climb,' but third party 'worth trying': Larry Hogan

Physicians and social media: If you see something, say something?

Readout Newsletter: Bluebird, CVS, Contineum

Future doctors should be trained to promote social change

focus

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

The cancer drug shortage isn’t new — and neither are the solutions

Neuroscience’s long legacy of racism

Medical records are filled with copy

Couple fighting to bring baby home from Mexico are finally reunited

23andMe had bad news about my health. I wish a person had delivered it

Neuroscience’s long legacy of racism

What does generative AI mean for health care? We asked experts

5 to watch: Tech startups trying to solve health care's staffing crisis

Hepatitis C has a cure — but many Americans still lack access to it

Leading voice in opioid treatment defends methadone clinic system

focus

New warning issued for rebooking air travel after delays, cancellations

Plastic surgeons increase patient psychiatric screenings

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

'Reaching a detente': STAT's Helen Branswell on covering Covid

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

Gilgo Beach murders: What questions remain following Rex Heuermann's arrest?

focus

focus

leisure time

Wikipedia